Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LITT Followed by Hypofractionated RT for Recurrent Gliomas

NCT: NCT04181684 · ACTIVE_NOT_RECRUITING

NCT IDNCT04181684
StatusACTIVE_NOT_RECRUITING
Start Date2020-01-08
Completion2026-12
SponsorUniversity of Maryland, Baltimore (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with recurrent gliomas.

Frequently Asked Questions

What is LITT Followed by Hypofractionated RT for Recurrent Gliomas?

LITT Followed by Hypofractionated RT for Recurrent Gliomas is a clinical trial registered under NCT04181684. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04181684?

The current status of NCT04181684 (LITT Followed by Hypofractionated RT for Recurrent Gliomas) is: ACTIVE_NOT_RECRUITING.

When did LITT Followed by Hypofractionated RT for Recurrent Gliomas start?

LITT Followed by Hypofractionated RT for Recurrent Gliomas started on 2020-01-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.